Association of adiponectin protein and ADIPOQ gene variants with lumbar disc degeneration

Khabour,Omar  F.; Abu‑Rumeh,Lama; Al‑Jarrah,Muhammed; Jamous,Mohammed; Alhashimi,Farah

doi:10.3892/etm.2014.1909

Association of adiponectin protein and ADIPOQ gene variants with lumbar disc degeneration

Authors:
- Omar F. Khabour
- Lama Abu‑Rumeh
- Muhammed Al‑Jarrah
- Mohammed Jamous
- Farah Alhashimi
View Affiliations

Affiliations: Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, Jordan University of Science and Technology, Irbid 22110, Jordan, Department of Rehabilitation Sciences, Faculty of Applied Medical Sciences, Jordan University of Science and Technology, Irbid 22110, Jordan, Department of Neurosurgery, Faculty of Applied Medical Sciences, Jordan University of Science and Technology, Irbid 22110, Jordan
Published online on: August 18, 2014 https://doi.org/10.3892/etm.2014.1909
Pages: 1340-1344

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Lumbar disc degeneration (LDD) is a widespread public health problem that may lead to disability and loss of productivity. Adiponectin is an adipokine secreted by adipose tissue and has been shown to be involved in cartilage homeostasis. In the present study, the association between the rs266729 (‑11377C/G) and rs2241766 (45T/G) single nucleotide polymorphisms (SNPs) in the adiponectin gene (ADIPOQ) and LDD was investigated. In addition, the correlation between the plasma adiponectin level and LDD was examined. A total of 289 subjects, 168 patients with LDD and 122 healthy individuals, were recruited in the study. All subjects were genotyped for rs266729 and rs2241766 SNPs using polymerase chain reaction‑restriction fragment length polymorphism. Circulating levels of adiponectin protein were measured using the ELISA technique. A strong association was found between adiponectin level and LDD (P<0.01), where high levels of adiponectin were found in patients compared with healthy controls. The increase in adiponectin level was not affected by gender. However, no significant differences were found in the genotype distribution or allelic frequency of the two examined polymorphisms between patients with LDD and healthy controls (P>0.05). In conclusion, adiponectin appears to be elevated in patients with LDD. The rs266729 and rs2241766 SNPs in the ADIPOQ gene are not associated with LDD.

View Figures

View References

1	Fantuzzi G: Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol. 115:911–919. 2005. View Article : Google Scholar : PubMed/NCBI
2	Conde J, Scotece M, Gómez R, et al: Adipokines: biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity. Biofactors. 37:413–420. 2011. View Article : Google Scholar : PubMed/NCBI
3	Ouchi N, Parker JL, Lugus JJ and Walsh K: Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 11:85–97. 2011. View Article : Google Scholar : PubMed/NCBI
4	Hotta K, Funahashi T, Arita Y, et al: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 20:1595–1599. 2000. View Article : Google Scholar : PubMed/NCBI
5	Kadowaki T, Yamauchi T, Kubota N, et al: Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. 116:1784–1792. 2006. View Article : Google Scholar : PubMed/NCBI
6	Toussirot E, Gaugler B, Bouhaddi M, et al: Elevated adiponectin serum levels in women with systemic autoimmune diseases. Mediators Inflamm. 2010:9384082010. View Article : Google Scholar : PubMed/NCBI
7	Kang EH, Lee YJ, Kim TK, et al: Adiponectin is a potential catabolic mediator in osteoarthritis cartilage. Arthritis Res Ther. 12:R2312010. View Article : Google Scholar : PubMed/NCBI
8	Koskinen A, Juslin S, Nieminen R, et al: Adiponectin associates with markers of cartilage degradation in osteoarthritis and induces production of proinflammatory and catabolic factors through mitogen-activated protein kinase pathways. Arthritis Res Ther. 13:R1842011. View Article : Google Scholar
9	Rho YH, Solus J, Sokka T, et al: Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. Arthritis Rheum. 60:1906–1914. 2009. View Article : Google Scholar : PubMed/NCBI
10	Aǧbaht K, Gürlek A, Karakaya J and Bayraktar M: Circulating adiponectin represents a biomarker of the association between adiposity and bone mineral density. Endocrine. 35:371–379. 2009.PubMed/NCBI
11	Doherty AL, Battaglino RA, Donovan J, et al: Adiponectin is a candidate biomarker of lower extremity bone density in men with chronic spinal cord injury. J Bone Miner Res. 29:251–259. 2014. View Article : Google Scholar : PubMed/NCBI
12	Magni P, Dozio E, Galliera E, Ruscica M and Corsi MM: Molecular aspects of adipokine-bone interactions. Curr Mol Med. 10:522–532. 2010.PubMed/NCBI
13	Mohiti-Ardekani J, Soleymani-Salehabadi H, Owlia MB and Mohiti A: Relationships between serum adipocyte hormones (adiponectin, leptin, resistin), bone mineral density and bone metabolic markers in osteoporosis patients. J Bone Miner Metab. 32:400–404. 2014. View Article : Google Scholar
14	Jim JJ, Noponen-Hietala N, Cheung KM, et al: The TRP2 allele of COL9A2 is an age-dependent risk factor for the development and severity of intervertebral disc degeneration. Spine (Phila Pa 1976). 30:2735–2742. 2005. View Article : Google Scholar : PubMed/NCBI
15	Lin WP, Wang XJ, Wang CR, et al: Polymorphism in the hypoxia-inducible factor 1alpha gene may confer susceptibility to LDD in Chinese cohort. PLoS One. 8:e731582013. View Article : Google Scholar : PubMed/NCBI
16	Näkki A, Videman T, Kujala UM, et al: Candidate gene association study of magnetic resonance imaging-based hip osteoarthritis (OA): evidence for COL9A2 gene as a common predisposing factor for hip OA and lumbar disc degeneration. J Rheumatol. 38:747–752. 2011.PubMed/NCBI
17	Seki S, Kawaguchi Y, Mori M, et al: Association study of COL9A2 with lumbar disc disease in the Japanese population. J Hum Genet. 51:1063–1067. 2006. View Article : Google Scholar : PubMed/NCBI
18	Solovieva S, Lohiniva J, Leino-Arjas P, et al: Intervertebral disc degeneration in relation to the COL9A3 and the IL-1ss gene polymorphisms. Eur Spine J. 15:613–619. 2006. View Article : Google Scholar : PubMed/NCBI
19	Zawilla NH, Darweesh H, Mansour N, et al: Matrix metalloproteinase-3, vitamin D receptor gene polymorphisms, and occupational risk factors in lumbar disc degeneration. J Occup Rehabil. 24:370–381. 2014. View Article : Google Scholar : PubMed/NCBI
20	Khabour OF, Mesmar FS, Alatoum MA, Gharaibeh MY and Alzoubi KH: Associations of polymorphisms in adiponectin and leptin genes with men’s longevity. Aging Male. 13:188–193. 2010.
21	Khabour OF, Wehaibi SH, Al-Azzam SI, Alzoubi KH and El-Akawi ZJ: Association of adiponectin with hypertension in type 2 diabetic patients: the gender effect. Clin Exp Hypertens. 35:361–366. 2013. View Article : Google Scholar : PubMed/NCBI
22	Al-Azzam SI, Alkhateeb AM, Alzoubi KH, et al: Atorvastatin treatment modulates the interaction between leptin and adiponectin, and the clinical parameters in patients with type II diabetes. Exp Ther Med. 6:1565–1569. 2013.PubMed/NCBI
23	Nedvidkova J, Smitka K, Kopsky V and Hainer V: Adiponectin, an adipocyte-derived protein. Physiol Res. 54:133–140. 2005.
24	Gomez R, Lago F, Gomez-Reino J, Dieguez C and Gualillo O: Adipokines in the skeleton: influence on cartilage function and joint degenerative diseases. J Mol Endocrinol. 43:11–18. 2009. View Article : Google Scholar : PubMed/NCBI
25	Kanazawa I: Adiponectin in metabolic bone disease. Curr Med Chem. 19:5481–5492. 2012. View Article : Google Scholar
26	Ruscica M, Steffani L and Magni P: Adiponectin interactions in bone and cartilage biology and disease. Vitam Horm. 90:321–339. 2012. View Article : Google Scholar : PubMed/NCBI
27	Giles JT, van der Heijde DM and Bathon JM: Association of circulating adiponectin levels with progression of radiographic joint destruction in rheumatoid arthritis. Ann Rheum Dis. 70:1562–1568. 2011. View Article : Google Scholar : PubMed/NCBI
28	Klein-Wieringa IR, van der Linden MP, Knevel R, et al: Baseline serum adipokine levels predict radiographic progression in early rheumatoid arthritis. Arthritis Rheum. 63:2567–2574. 2011. View Article : Google Scholar : PubMed/NCBI
29	Senolt L, Pavelka K, Housa D and Haluzik M: Increased adiponectin is negatively linked to the local inflammatory process in patients with rheumatoid arthritis. Cytokine. 35:247–252. 2006. View Article : Google Scholar : PubMed/NCBI
30	Wang F, Wang PX, Wu XL, et al: Deficiency of adiponectin protects against ovariectomy-induced osteoporosis in mice. PLoS One. 8:e684972013. View Article : Google Scholar : PubMed/NCBI
31	Johansson H, Oden A, Lerner UH, et al: High serum adiponectin predicts incident fractures in elderly men: Osteoporotic fractures in men (MrOS) Sweden. J Bone Miner Res. 27:1390–1396. 2012. View Article : Google Scholar : PubMed/NCBI
32	Lago R, Gomez R, Otero M, et al: A new player in cartilage homeostasis: adiponectin induces nitric oxide synthase type II and pro-inflammatory cytokines in chondrocytes. Osteoarthritis Cartilage. 16:1101–1109. 2008. View Article : Google Scholar : PubMed/NCBI
33	Barbour KE, Zmuda JM, Boudreau R, et al: Adipokines and the risk of fracture in older adults. J Bone Miner Res. 26:1568–1576. 2011. View Article : Google Scholar : PubMed/NCBI
34	Eglit T, Lember M, Ringmets I and Rajasalu T: Gender differences in serum high-molecular-weight adiponectin levels in metabolic syndrome. Eur J Endocrinol. 168:385–391. 2013. View Article : Google Scholar : PubMed/NCBI
35	Al-Daghri NM, Al-Attas OS, Alokail MS, et al: Gender differences exist in the association of leptin and adiponectin levels with insulin resistance parameters in prepubertal Arab children. J Pediatr Endocrinol Metab. 24:427–432. 2011.PubMed/NCBI
36	Tabatabaei-Malazy O, Hasani-Ranjbar S, Amoli MM, et al: Gender-specific differences in the association of adiponectin gene polymorphisms with body mass index. Rev Diabet Stud. 7:241–246. 2010.PubMed/NCBI
37	Haluzik M, Parizkova J and Haluzik MM: Adiponectin and its role in the obesity-induced insulin resistance and related complications. Physiol Res. 53:123–129. 2004.PubMed/NCBI
38	Hoffstedt J, Arvidsson E, Sjolin E, Wahlen K and Arner P: Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance. J Clin Endocrinol Metab. 89:1391–1396. 2004. View Article : Google Scholar : PubMed/NCBI
39	Trevaskis JL, Gawronska-Kozak B, Sutton GM, et al: Role of adiponectin and inflammation in insulin resistance of Mc3r and Mc4r knockout mice. Obesity (Silver Spring). 15:2664–2672. 2007. View Article : Google Scholar : PubMed/NCBI
40	Hashemi M, Hanafi Bojd H, Eskandari Nasab E, et al: Association of adiponectin rs1501299 and rs266729 gene polymorphisms with nonalcoholic fatty liver disease. Hepat Mon. 13:e95272013. View Article : Google Scholar : PubMed/NCBI
41	Hsiao TJ, Wu LS, Huang SY and Lin E: A common variant in the adiponectin gene on weight loss and body composition under sibutramine therapy in obesity. Clin Pharmacol. 2:105–110. 2010.
42	Rizk NM, El-Menyar A, Marei I, et al: Association of adiponectin gene polymorphism (+T45G) with acute coronary syndrome and circulating adiponectin levels. Angiology. 64:257–265. 2013. View Article : Google Scholar : PubMed/NCBI
43	Younossi ZM, Jarrar M, Nugent C, et al: A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH). Obes Surg. 18:1430–1437. 2008. View Article : Google Scholar : PubMed/NCBI